InvestorsHub Logo
Followers 49
Posts 3878
Boards Moderated 0
Alias Born 09/14/2007

Re: Klinsmann post# 173

Wednesday, 06/26/2019 12:20:39 PM

Wednesday, June 26, 2019 12:20:39 PM

Post# of 278
The company had a prearranged offering which put a lid on the price. It was a small offering, plus they had a convertible deal with a discount that ends today. Keep in mind this is a tiny company with capital needs, and no guarantee the FDA would approve their product. The stock price should start to melt upward with the selling pressure easing soon. Also, the company is going on the Russell Micro Cap Index starting July 1. The stock should get some demand. Anyway, Esocheck is going to be a good product for PAVM.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PAVM News